These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26047581)

  • 1. A plea for uniform terminology for patients with urothelial carcinoma treated with chemotherapy prior to radical cystectomy: induction versus neoadjuvant chemotherapy.
    Liedberg F; Gudjonsson S; Kollberg P; Ullén A
    Eur Urol; 2015 Oct; 68(4):742-3. PubMed ID: 26047581
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage pT0 after radical cystectomy: are all patients equal?
    Chromecki TF; Cha EK; Shariat SF;
    Eur Urol; 2011 Sep; 60(3):603-4. PubMed ID: 21665358
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial.
    Chang SS
    J Urol; 2016 Jan; 195(1):63-4. PubMed ID: 26699956
    [No Abstract]   [Full Text] [Related]  

  • 4. Towards effective adjuvant treatment for urothelial cancer.
    Siefker-Radtke AO; Gao J
    Lancet Oncol; 2015 Jan; 16(1):9-10. PubMed ID: 25498220
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
    Fleischmann A; Thalmann GN; Perren A; Seiler R
    Am J Surg Pathol; 2014 Mar; 38(3):325-32. PubMed ID: 24525502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial. Lancet Oncol 2015;16:76-86.
    Ohlmann CH; Stöckle M
    Eur Urol; 2015 Dec; 68(6):1104-5. PubMed ID: 26320378
    [No Abstract]   [Full Text] [Related]  

  • 7. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in locally advanced bladder cancer.
    Lu K
    Lancet Oncol; 2015 Mar; 16(3):e103-4. PubMed ID: 25752555
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.
    Keck B; Wach S; Stoehr R; Kunath F; Bertz S; Lehmann J; Stöckle M; Taubert H; Wullich B; Hartmann A
    BMC Cancer; 2013 Feb; 13():71. PubMed ID: 23394492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcomatoid variant of urothelial carcinoma of the urinary bladder.
    Bansal A; Kumar N; Sharma SC
    J Cancer Res Ther; 2013; 9(4):571-3. PubMed ID: 24518698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.
    Sternberg CN; Bellmunt J; Sonpavde G; Siefker-Radtke AO; Stadler WM; Bajorin DF; Dreicer R; George DJ; Milowsky MI; Theodorescu D; Vaughn DJ; Galsky MD; Soloway MS; Quinn DI;
    Eur Urol; 2013 Jan; 63(1):58-66. PubMed ID: 22917984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy in patients with invasive bladder cancer.
    Vaughn DJ; Malkowicz SB
    Urol Clin North Am; 2005 May; 32(2):231-7. PubMed ID: 15862620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs for urothelial carcinoma.
    Gartrell BA; Sonpavde G
    Expert Opin Emerg Drugs; 2013 Dec; 18(4):477-94. PubMed ID: 24195728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
    Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
    Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival.
    Parker WP; Ho PL; Melquist JJ; Scott K; Holzbeierlein JM; Lopez-Corona E; Kamat AM; Lee EK
    J Urol; 2015 May; 193(5):1494-9. PubMed ID: 25451834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy.
    Joudi FN; Dahmoush L; Spector DM; Konety BR
    Urol Oncol; 2006; 24(5):403-6. PubMed ID: 16962489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid urothelial carcinoma of the bladder.
    Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T
    Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.
    Potretzke A; Hillman L; Wong K; Shi F; Brower R; Mai S; Cetnar JP; Abel EJ; Downs TM
    Urol Oncol; 2014 Jul; 32(5):631-6. PubMed ID: 24629498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G; Lerner SP
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate.
    Lavery HJ; Stensland KD; Niegisch G; Albers P; Droller MJ
    J Urol; 2014 Apr; 191(4):898-906. PubMed ID: 24300483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.